Evidence map›Paper›PMID 40033691›Full record

ArticleBalkan medical journal2025

Clinical Characteristics of Nail Unit Melanoma in Türkiye: The Experience of Two Tertiary Dermatology Centers.

Tuğba Atcı, Muhammed Burak Günay, Şirin Yaşar, Nesimi Büyükbabani, Pembegül Güneş, Şule Öztürk Sarı, Zuhal Kuş Silav, Can Baykal, Fatih Göktay

Abstract read
In one paragraph

Article in Balkan medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Challenges in the Diagnosis and Management of Nail Melanocytic Disorders.Clinical, cosmetic and investigational dermatology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tuğba AtcıDepartment of Dermatology and Venereology, İstanbul University, İstanbul Faculty of Medicine, İstanbul, Türkiye.ORCID 0000-0003-0505-3788
Muhammed Burak GünayDepartment of Dermatology and Venereology, İstanbul University, İstanbul Faculty of Medicine, İstanbul, Türkiye.ORCID 0000-0002-1656-6290
Şirin YaşarClinic of Dermatology and Venereology, University of Health Sciences Türkiye, Haydarpaşa Numune Training and Research Hospital, İstanbul, Türkiye.ORCID 0000-0002-4110-1874
Nesimi BüyükbabaniDepartment of Pathology, Koç University School of Medicine, İstanbul, Türkiye.ORCID 0000-0003-0472-4826
Pembegül GüneşClinic of Pathology, University of Health Sciences Türkiye, Haydarpaşa Numune Training and Research Hospital, İstanbul, Türkiye.ORCID 0000-0002-4982-5156
Şule Öztürk SarıDepartment of Pathology, İstanbul University, İstanbul Faculty of Medicine, İstanbul, Türkiye.ORCID 0000-0003-0439-5954
Zuhal Kuş SilavClinic of Pathology, University of Health Sciences Türkiye, Haydarpaşa Numune Training and Research Hospital, İstanbul, Türkiye.ORCID 0000-0002-6586-8092
Can BaykalDepartment of Dermatology and Venereology, İstanbul University, İstanbul Faculty of Medicine, İstanbul, Türkiye.ORCID 0000-0001-6004-3166
Fatih GöktayClinic of Dermatology and Venereology, University of Health Sciences Türkiye, Haydarpaşa Numune Training and Research Hospital, İstanbul, Türkiye.ORCID 0000-0002-2380-7697

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The literature on the clinical presentations of nail unit melanoma (NUM) in different countries is limited. Aims: To assess the specific clinical characteristics of NUM in Türkiye. Study Design: A retrospective cross sectional study. Methods: Patients with NUM in two centers were retrospectively evaluated for their clinicopathological features, including the location, laterality, destruction of the nail plate, erosion or ulceration, presence of longitudinal melanonychia (LM), Hutchinson's sign (HS), and the absence of pigmentation and Breslow thickness. These variables were compared in terms of the main location of the NUMs (fingernail versus toenail). Results: A total of 37 patients (54.1% female) of mean age 61.9 ± 14.8 years were enrolled. In most cases, NUMs were located in the fingernails (62.2%), with the most common location being the thumbnails (45.9%), followed by the big toenails (32.4%). Five cases had in situ melanoma presenting with LM. The mean Breslow thickness of invasive NUM lesions (n = 26) was 4.7 ± 4.1 mm (median: 3). Although all in situ NUMs were located on the hands, no statistically significant difference was noted in the Breslow thickness of invasive NUMs on the toenails and fingernails. NUMs were hypomelanotic/amelanotic in 10 (27%) patients. LM was clinically evident in 40.5% of the patients and was significantly more frequently observed on fingernails. The HS of the nail folds was noted in 40.5% of the patients, with the proximal (73.3%) and distal (73.3%) nail folds being most commonly involved. Total or partial destruction of the nail plate was recorded in 24.3% and 51.4% of the patients, respectively. Erosion and/or ulceration on the surface of the NUM was clinically present in most (75.7%) cases. Invasive NUMs associated with LM (n = 10) displayed partial destruction of the nail plate (n = 9), erosion and/or ulceration on the tumor surface (n = 7), and HS (n = 6). Conclusion: The clinical characteristics of patients with NUM, such as more common localization on the hands, a high rate of preference for thumbnail and big toe, and the ratio of HS, were similar to the studies reported from diverse countries. Partial destruction of the nail plate is an important clinical feature of NUM. Furthermore, LM is more frequently observed in NUMs on the fingernails.

Indexed as

MelanomaNail DiseasesSkin NeoplasmsAdultAgedAged, 80 and overCross-Sectional StudiesDermatologyFemaleHumansMaleMiddle AgedNailsRetrospective StudiesTertiary Care CentersTurkey

Identifiers

PMID40033691
PMCPMC11881541

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.